Urotensin II induces rat cardiomyocyte hypertrophy via the transient oxidization of Src homology 2-containing tyrosine phosphatase and transactivation of epidermal growth factor receptor

Molecular Pharmacology

Volumn 76, Issue 6, 2009, Pages 1186-1195

  Liu, Ju Chi ^a   Chen, Cheng Hsien ^a   Chen, Jin Jer ^b   Cheng, Tzu Hurng ^c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ACETYLCYSTEINE; APOCYNIN; EPIDERMAL GROWTH FACTOR RECEPTOR; MALACHITE GREEN; PROTEIN TYROSINE PHOSPHATASE 1B; PROTEIN TYROSINE PHOSPHATASE SHP 2; REACTIVE OXYGEN METABOLITE; UROTENSIN II;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME METABOLISM; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; TRANSACTIVATION;

ANIMALS; BLOTTING, WESTERN; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GENE KNOCKDOWN TECHNIQUES; HYPERTROPHY; MYOCYTES, CARDIAC; OXIDATION-REDUCTION; PROTEIN TYROSINE PHOSPHATASES; RATS; REACTIVE OXYGEN SPECIES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SHC SIGNALING ADAPTOR PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; UROTENSINS;

EID: 73149119394     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.109.058297     Document Type: Article

References (21)

1. Bousette N and Giaid A (2006) Urotensin-II and cardiovascular diseases. Curr Hypertens Rep 8:479-483.
2. Chao HH, Hong HJ, Liu JC, Lin JW, Chen YL, Chiu WT, Wu CH, Shyu KG, and Cheng TH (2007) Leptin stimulates endothelin-1 expression via extracellular signal-regulated kinase by epidermal growth factor receptor transactivation in rat aortic smooth muscle cells. Eur J Pharmacol 573:49-54.
3. Chen CH, Cheng TH, Lin H, Shih NL, Chen YL, Chen YS, Cheng CF, Lian WS, Meng TC, Chiu WT, et al. (2006) Reactive oxygen species generation is involved in epidermal growth factor receptor transactivation through the transient oxidization of Src homology 2-containing tyrosine phosphatase in endothelin-1 signaling pathway in rat cardiac fibroblasts. Mol Pharmacol 69:1347-1355.
4. Chen YL, Liu JC, Loh SH, Chen CH, Hong CY, Chen JJ, and Cheng TH. (2008) Involvement of reactive oxygen species in urotensin II-induced proliferation of cardiac fibroblasts. Eur J Pharmacol 593:24-29.
5. Cheng TH, Liu JC, Lin H, Shih NL, Chen YL, Huang MT, Chan P, Cheng CF, and Chen JJ (2004) Inhibitory effect of resveratrol on angiotensin II-induced cardiomyocyte hypertrophy. Naunyn Schmiedebergs Arch Pharmacol 369:239-244.
6. Cheng TH, Shih NL, Chen CH, Lin H, Liu JC, Chao HH, Liou JY, Chen YL, Tsai HW, Chen YS, et al. (2005a) Role of mitogen-activated protein kinase pathway in reactive oxygen species-mediated endothelin-1-induced beta-myosin heavy chain gene expression and cardiomyocyte hypertrophy. J Biomed Sci 12:123-133.
7. Cheng TH, Shih NL, Chen SY, Lin JW, Chen YL, Chen CH, Lin H, Cheng CF, Chiu WT, Wang DL, et al. (2005b) Nitric oxide inhibits endothelin-1-induced cardiomy-ocyte hypertrophy through cGMP-mediated suppression of extracellular-signal regulated kinase phosphorylation. Mol Pharmacol 68:1183-1192.
8. Cheng TH, Shih NL, Chen SY, Wang DL, and Chen JJ (1999) Reactive oxygen species modulate endothelin-I-induced c-fos gene expression in cardiomyocytes. Cardiovasc Res 41:654-662.
9. Djordjevic T, BelAiba RS, Bonello S, Pfeilschifter J, Hess J, and Görlach A (2005) Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells. Arterioscler Thromb Vasc Biol 25:519-525.
10. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals, 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC.
11. Liebmann C and Böhmer FD (2000) Signal transduction pathways of G proteincoupled receptors and their cross-talk with receptor tyrosine kinases: lessons from bradykinin signaling. Curr Med Chem 7:911-943.
12. Matsushita M, Shichiri M, Fukai N, Ozawa N, Yoshimoto T, Takasu N, and Hirata Y (2003) Urotensin II is an autocrine/paracrine growth factor for the porcine renal epithelial cell line, LLCPK1. Endocrinology 144:1825-1831.
13. Meng TC, Buckley DA, Galic S, Tiganis T, and Tonks NK (2004) Regulation of insulin signaling through reversible oxidation of the protein-tyrosine phosphatases TC45 and PTP1B. J Biol Chem 279:37716-37725.
14. Meng TC, Fukada T, and Tonks NK (2002) Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 9:387-399.
15. Ni YG, Berenji K, Wang N, Oh M, Sachan N, Dey A, Cheng J, Lu G, Morris DJ, Castrillon DH, et al. (2006) Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling. Circulation 114:1159-1168.
16. Onan D, Pipolo L, Yang E, Hannan RD, and Thomas WG (2004) Urotensin II promotes hypertrophy of cardiac myocytes via mitogen-activated protein kinases. Mol Endocrinol 18:2344-2354.
17. Papadopoulos P, Bousette N, and Giaid A (2008) Urotensin-II and cardiovascular remodeling. Peptides 29:764-769.
18. Saffitz JE, Hames KY, and Kanno S (2007) Remodeling of gap junctions in ischemic and nonischemic forms of heart disease. J Membr Biol 218:65-71.
19. Tzanidis A, Hannan RD, Thomas WG, Onan D, Autelitano DJ, See F, Kelly DJ, Gilbert RE, and Krum H (2003) Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy. Circ Res 93:246-253.
20. Zhang YG, Li YG, Liu BG, Wei RH, Wang DM, Tan XR, Bu DF, Pang YZ, and Tang CS (2007) Urotensin II accelerates cardiac fibrosis and hypertrophy of rats induced by isoproterenol. Acta Pharmacol Sin 28:36-43.
21. Zou Y, Nagai R, and Yamazaki T (2001) Urotensin II induces hypertrophic responses in cultured cardiomyocytes from neonatal rats. FEBS Lett 508:57-60.